Andrew ROBERTS

The Walter and Eliza Hall Institute of Medical Research, Australia

Andrew Roberts is the Metcalf Chair of Leukaemia Research at the University of Melbourne, a clinical haematologist at the Royal Melbourne Hospital and Petermac and Head of Clinical Translation at the Walter & Eliza Hall Institute.  His major research interests are the development of new treatments for leukaemia, lymphoma and myeloma through translational and clinical research. He has been an academic leader in the clinical development of the novel targeted anti-cancer drug, venetoclax, from the research laboratory through clinical trials to regulatory approval in many countries for use in treatment of leukaemia patients. He was President of the Haematology Society of Australia and New Zealand 2005 – 07, and Chair of the board of the Cancer Council Victoria 2013 – 17. He is a director of the national collaborative clinical trials group for blood cancers, and advises the Australian Government on the cost-effectiveness of medicines. In 2015, he was the first non-North American to serve as Scientific Co-Chair of the American Society of Hematology Annual Meeting.